+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Life Science Tools Market by Technology (Cell Biology Technology, Genomic Technology, Proteomics Technology), Product (Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry), Offerings, Lab Ownership, Lab Size, End-User - Forecast 2023-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674540
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Life Science Tools Market size was estimated at USD 184.17 billion in 2022, USD 203.93 billion in 2023, and is expected to grow at a CAGR of 11.15% to reach USD 429.19 billion by 2030.

Life sciences refer to the unit of science that studies living organisms, including biology, botany, zoology, microbiology, physiology, and biochemistry. Various instruments, consumables, reagents, and other services are used to study life science. The prevalence of chronic diseases worldwide is raising the need for improved tools for the early diagnosis of diseases. The favorable investment landscape to accelerate R&D in the biotechnological sector for its implications in health and medicine facilitates using life science tools. However, the high cost of implementation and maintenance and the quality control issues associated with using life science tools may impede their adoption by the end-use industries. Moreover, the rising applications of genomics and proteomics for precision medicine and breakthrough advancements in life science tools are expected to encourage their deployment across the end-use industries.

Regional Insights

The life science tools market is evolving in the Americas owing to the highly valued medical and pharmaceutical sector, rapid adoption of genomics, proteomics, oncology, and diagnostic screening, and major players continuously developing advanced tools for life science research. A well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is encouraging the life science tools market growth in the Americas. Increasing research and development (R&D) expenditure to advance medical research and the growing adoption of innovative and advanced tools among biopharmaceutical companies are facilitating the use of life science tools in the APAC region. Rising investments in research and development of healthcare and pharmaceutical products, growing consumer expenditure on advanced healthcare products to treat chronic diseases, and supportive government initiatives for life science and pharmaceutical sector development are expanding the utilization of life science tools in the EMEA region. The ongoing collaborations, acquisitions, and embracing of digital technologies can increase production and are expected to contribute to the growth of the life science tools market worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Life Science Tools Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Life Science Tools Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux SA, Bruker Corporation, Cardinal Health, Inc., Carl Zeiss AG, Charles River Laboratories International, Inc., Danaher Corporation, Diagnóstica Longwood S.L., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., GE Healthcare Technologies Inc., Genscript Biotech Corporation, Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Illumina, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., Luminex Corporation, Merck KGaA, Mettler-Toledo International Inc., New England Biolabs, Inc., Oxford Instruments PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics Incorporated, Repligen Corporation, Sartorius AG, SGS SA, Shimadzu Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Life Science Tools Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Cell Biology Technology
    • Genomic Technology
    • Proteomics Technology
  • Product
    • Cell Culture Systems & 3D Cell Culture
      • Media
      • Reagents
      • Sera
    • Cloning & Genome Engineering
    • Flow Cytometry
    • Liquid Chromatography
    • Mass Spectrometry
    • Microscopy & Electron Microscopy
    • Next Generation Sequencing
    • Nuclear Magnetic Resonance
    • Nucleic Acid Microarray
    • Nucleic Acid Preparation
    • PCR & qPCR
    • Sanger Sequencing
    • Transfection Devices & Gene Delivery Technologies
  • Offerings
    • Consumables
    • Instrument
    • Services
  • Lab Ownership
    • Private
    • Public
  • Lab Size
    • Large
    • Medium
    • Small
  • End-User
    • Academic Research Institutes
    • Biotechnology Companies
    • Contract Research Organization/ Contract Manufacturing Organization
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Life Science Tools Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Life Science Tools Market?
  3. What are the technology trends and regulatory frameworks in the Life Science Tools Market?
  4. What is the market share of the leading vendors in the Life Science Tools Market?
  5. Which modes and strategic moves are suitable for entering the Life Science Tools Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Life Science Tools Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need for efficient tools for early diagnosis of chronic diseases
5.1.1.2. Surge in investments toward biotech R&D activities from government and non-government organizations
5.1.1.3. Applications of genomic and proteomic technologies for precision medicine
5.1.2. Restraints
5.1.2.1. High cost of life science tools
5.1.3. Opportunities
5.1.3.1. Robust technological advancements in life science tools
5.1.3.2. Rapid progress and development of life-science tools in the single-cell isolation and analysis
5.1.4. Challenges
5.1.4.1. Quality control issues associated with life science tools
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Increase in life science research activities and ongoing advancements in life science tools in the Americas
5.3.2. Growing focus on medical research to alleviate the burden of diseases in the APAC region
5.3.3. Government investments and initiatives for the advancement of the healthcare sector in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Life Science Tools Market, by Technology
6.1. Introduction
6.2. Cell Biology Technology
6.3. Genomic Technology
6.4. Proteomics Technology
7. Life Science Tools Market, by Product
7.1. Introduction
7.2. Cell Culture Systems & 3D Cell Culture
7.3.1. Media
7.3.2. Reagents
7.3.3. Sera
7.3. Cloning & Genome Engineering
7.4. Flow Cytometry
7.5. Liquid Chromatography
7.6. Mass Spectrometry
7.7. Microscopy & Electron Microscopy
7.8. Next Generation Sequencing
7.9. Nuclear Magnetic Resonance
7.10. Nucleic Acid Microarray
7.11. Nucleic Acid Preparation
7.12. PCR & qPCR
7.13. Sanger Sequencing
7.14. Transfection Devices & Gene Delivery Technologies
8. Life Science Tools Market, by Offerings
8.1. Introduction
8.2. Consumables
8.3. Instrument
8.4. Services
9. Life Science Tools Market, by Lab Ownership
9.1. Introduction
9.2. Private
9.3. Public
10. Life Science Tools Market, by Lab Size
10.1. Introduction
10.2. Large
10.3. Medium
10.4. Small
11. Life Science Tools Market, by End-User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organization/ Contract Manufacturing Organization
11.5. Diagnostic Laboratories
11.6. Hospitals
12. Americas Life Science Tools Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Life Science Tools Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Life Science Tools Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
15.3.1. Merger & Acquisition
15.3.1.1. Berkeley Lights Completed Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
15.3.1.2. Cytek Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
15.3.1.3. Agilent Acquired Life Sciences Company Avida Biomed
15.3.2. Agreement, Collaboration, & Partnership
15.3.2.1. Patient Square Capital Partnered with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities
15.3.2.2. SCIEX collaborates with Beckman Coulter Life Sciences to bring automation to the Echo MS system
15.3.2.3. Tecan collaborates with Element Biosciences to provide benchtop NGS
15.3.2.4. Agilent to collaborate with Quest Diagnostics to extend access to the Agilent Resolution ctDx FIRST Liquid Biopsy test
15.3.2.5. QIAGEN and Helix Launched Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
15.3.2.6. Bruker enters into a strategic partnership with Biognosys
15.3.3. New Product Launch & Enhancement
15.3.3.1. Bruker advances NMR magnet portfolio, innovates in industrial solutions
15.3.3.2. Illumina, GenoScreen launched next-generation sequencing innovation to eliminate TB
15.3.3.3. Waters Corporation launched the next generation Alliance iS HPLC System
15.3.3.4. Neogen Launches New Genomic Management Technology
15.3.3.5. Thermo Fisher Launches Next-Generation Sequencing Platform for Labs
15.3.4. Investment & Funding
15.3.4.1. BIO-TECHNE completes investment in WILSON WOLF MANUFACTURING
15.3.4.2. UK boosts life science innovation with £277 million funding
15.3.4.3. Novo Holdings invests in a proteomics technology company, Evosep
15.3.4.4. MedGenome Raises USD 50M To Map The Human Genome
15.3.5. Award, Recognition, & Expansion
15.3.5.1. GenScript expands footprint in Singapore to provide premium Gene Synthesis service
15.3.5.2. Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado
15.3.5.3. Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
15.3.5.4. Charles River Labs expands CGT capabilities into Cheshire
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. 10x Genomics, Inc.
16.1.2. 3M Company
16.1.3. Abbott Laboratories
16.1.4. Abcam PLC
16.1.5. Agilent Technologies, Inc.
16.1.6. Avantor, Inc.
16.1.7. B. Braun SE
16.1.8. Becton, Dickinson, and Company
16.1.9. Bio-Rad Laboratories, Inc.
16.1.10. Bio-Techne Corporation
16.1.11. bioMérieux SA
16.1.12. Bruker Corporation
16.1.13. Cardinal Health, Inc.
16.1.14. Carl Zeiss AG
16.1.15. Charles River Laboratories International, Inc.
16.1.16. Danaher Corporation
16.1.17. Diagnóstica Longwood S.L.
16.1.18. Eppendorf SE
16.1.19. Eurofins Scientific SE
16.1.20. F. Hoffmann-La Roche Ltd.
16.1.21. Fulgent Genetics, Inc.
16.1.22. GE Healthcare Technologies Inc.
16.1.23. Genscript Biotech Corporation
16.1.24. Hitachi, Ltd.
16.1.25. HORIBA, Ltd.
16.1.26. ICON PLC
16.1.27. Illumina, Inc.
16.1.28. IQVIA Holdings Inc.
16.1.29. Laboratory Corporation of America Holdings
16.1.30. Lonza Group Ltd.
16.1.31. Luminex Corporation
16.1.32. Merck KGaA
16.1.33. Mettler-Toledo International Inc.
16.1.34. New England Biolabs, Inc.
16.1.35. Oxford Instruments PLC
16.1.36. PerkinElmer, Inc.
16.1.37. Promega Corporation
16.1.38. QIAGEN N.V.
16.1.39. Quest Diagnostics Incorporated
16.1.40. Repligen Corporation
16.1.41. Sartorius AG
16.1.42. SGS SA
16.1.43. Shimadzu Corporation
16.1.44. Takara Bio Inc.
16.1.45. Tecan Trading AG
16.1.46. Thermo Fisher Scientific Inc.
16.1.47. Waters Corporation
16.1.48. WuXi AppTec Co., Ltd
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. LIFE SCIENCE TOOLS MARKET RESEARCH PROCESS
FIGURE 2. LIFE SCIENCE TOOLS MARKET SIZE, 2022 VS 2030
FIGURE 3. LIFE SCIENCE TOOLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LIFE SCIENCE TOOLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. LIFE SCIENCE TOOLS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. LIFE SCIENCE TOOLS MARKET DYNAMICS
FIGURE 7. LIFE SCIENCE TOOLS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 8. LIFE SCIENCE TOOLS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. LIFE SCIENCE TOOLS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. LIFE SCIENCE TOOLS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. LIFE SCIENCE TOOLS MARKET SIZE, BY OFFERINGS, 2022 VS 2030 (%)
FIGURE 12. LIFE SCIENCE TOOLS MARKET SIZE, BY OFFERINGS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. LIFE SCIENCE TOOLS MARKET SIZE, BY LAB OWNERSHIP, 2022 VS 2030 (%)
FIGURE 14. LIFE SCIENCE TOOLS MARKET SIZE, BY LAB OWNERSHIP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. LIFE SCIENCE TOOLS MARKET SIZE, BY LAB SIZE, 2022 VS 2030 (%)
FIGURE 16. LIFE SCIENCE TOOLS MARKET SIZE, BY LAB SIZE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. LIFE SCIENCE TOOLS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 18. LIFE SCIENCE TOOLS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS LIFE SCIENCE TOOLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. AMERICAS LIFE SCIENCE TOOLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES LIFE SCIENCE TOOLS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 22. UNITED STATES LIFE SCIENCE TOOLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LIFE SCIENCE TOOLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LIFE SCIENCE TOOLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE TOOLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE TOOLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. LIFE SCIENCE TOOLS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 28. LIFE SCIENCE TOOLS MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • 10x Genomics, Inc.
  • 3M Company
  • Abbott Laboratories
  • Abcam PLC
  • Agilent Technologies, Inc.
  • Avantor, Inc.
  • B. Braun SE
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux SA
  • Bruker Corporation
  • Cardinal Health, Inc.
  • Carl Zeiss AG
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Diagnóstica Longwood S.L.
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Fulgent Genetics, Inc.
  • GE Healthcare Technologies Inc.
  • Genscript Biotech Corporation
  • Hitachi, Ltd.
  • HORIBA, Ltd.
  • ICON PLC
  • Illumina, Inc.
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Luminex Corporation
  • Merck KGaA
  • Mettler-Toledo International Inc.
  • New England Biolabs, Inc.
  • Oxford Instruments PLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Repligen Corporation
  • Sartorius AG
  • SGS SA
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • WuXi AppTec Co., Ltd

Methodology

Loading
LOADING...

Table Information